Effectiveness of intensified rotational combination chemotherapy for late hematologic relapse of childhood acute lymphoblastic leukemia

Blood

Volumn 88, Issue 3, 1996, Pages 831-837

  Rivera, Gaston K ^a   Hudson, Melissa M ^b   Liu, Qing ^b   Benaim, Ely ^b   Ribeiro, Raul C ^b   Crist, William M ^b   Pui, Ching Hon ^b  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; ASPARAGINASE; CYCLOPHOSPHAMIDE; CYTARABINE; ETOPOSIDE; HYDROCORTISONE; MERCAPTOPURINE; METHOTREXATE; PREDNISONE; TENIPOSIDE; VINCRISTINE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; ARTICLE; BRAIN LEUKEMIA; CANCER COMBINATION CHEMOTHERAPY; CANCER RECURRENCE; CANCER SURVIVAL; CHILD; CHILDHOOD LEUKEMIA; CLINICAL ARTICLE; FEMALE; HUMAN; INTRATHECAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MALE; METASTASIS; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; SKULL IRRADIATION; TREATMENT OUTCOME;

EID: 0029768850     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v88.3.831.bloodjournal883831     Document Type: Article

References (30)

1. Rivera GK, Aur RJA, Dahl GV, Pratt CB, Hustu HO, George SL, Mauer AM: Second cessation of therapy in childhood lymphocytic leukemia. Blood 53:1114, 1979
2. Chessells J, Leiper A, Rogers D: Outcome following late marrow relapse in childhood acute lymphocytic leukemia. J Clin Oncol 2:1088, 1984
3. Rivera GK, Buchanan G, Boyett JM, Camitta B, Ochs J, Kalwinsky D, Amylon M, Vietti TJ, Crist WM: Intensive retreatment of childhood acute lymphoblastic leukemia in first bone marrow relapse: A Pediatric Oncology Group Study. N Engl J Med 315: 273, 1986
4. Kumar P, Kun LE, Hustu HO, Mulhern RK, Hancock ML, Coffey D, Rivera GK: Survival outcome following isolated central nervous system relapse treated with additional chemotherapy and craniospinal irradiation in childhood acute lymphoblastic leukemia. Int J Radiat Oncol Biol Phys 31:477, 1995
5. Pui C-H, Bowman P, Ochs J, Dodge RK, Rivera GK: Cyclic combination chemotherapy for acute lymphoblastic leukemia recurring after elective cessation of therapy. Med Pediatr Oncol 16:21, 1988
6. Ribeiro RC, Rivera GK, Hudson M, Mulhern RK, Hancock ML, Kun L, Mahmoud H, Sandlund JT, Crist WM, Pui C-H: An intensive re-treatment protocol for children with an isolated CNS relapse of acute lymphoblastic leukemia. J Clin Oncol 13:333, 1995
7. Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DA, Gralnick HR, Sultan C: Proposals for the classification of the acute leukemias. French-American-British (FAB) Co-operative Group. Br J Haematol 33:451, 1976
8. Pui C-H, Aur RJA, Bowman P, Dahl GV, Dodge RK, George SL, Ochs J, Kalwinsky DK, Abromowitch M, Hustu HO, Simone JV: Failure of late intensification therapy to improve a poor result in childhood lymphoblastic leukemia. Cancer Res 44:3593, 1984
9. Pui C-H, Simone JV, Hancock ML, Evans WE, Williams DL, Bowman WP, Dahl GV, Dodge RK, Ochs J, Abromowitch M, Rivera GK: Impact of three methods of treatment intensification on acute lymphoblastic leukemia in children: Long-term results of St. Jude total therapy study X. Leukemia 6:150, 1992
10. Miller DR, Coccia PF, Bleyer WA, Lukens JN, Siegel SE, Sather HN, Hammond GD: Early response to induction therapy as a predictor of disease-free survival and late recurrence of childhood acute lymphoblastic leukemia: A report from the Childrens Cancer Study Group. J Clin Oncol 7:1807, 1989
11. Tubergen DG, Gilchrist GS, O'Brien RT, Coccia PF, Sather HN, Waskerwitz MJ, Hammond GD: Improved outcome with delayed intensification for children with acute lymphoblastic leukemia and intermediate presenting features: A Childrens Cancer Group Phase III Trial. J Clin Oncol 11:527, 1993
12. Goldie JH, Coldman AJ, Gudauskas GA: Rationale for use of alternating non-cross-resistant chemotherapy. Cancer Treat Rep 66:439, 1982
13. Kaplan EL, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457, 1958
14. Cox DR. Regression models and life-tables. J R Stat Soc 34:187, 1972
15. Sadowitz PD, Smith SD, Shuster J, Wharam MD, Buchanan GR, Rivera GK: Treatment of late bone marrow relapse in children with acute lymphoblastic leukemia. A Pediatric Oncology Group Study. Blood 81:602, 1993
16. Uderzo C, Valsecchi MG, Bacigalupo A, Meloni G, Messina C, Polchi P, DiGirolamo G, Dini G, Miniero R, Locatelli F, Colella R, Tamaro P, loCurto M, DiTullio MT, Maseru G: Treatment of childhood acute lymphoblastic leukemia in second remission with allogeneic bone marrow transplantation and chemotherapy: Ten-year experience of the Italian Bone Marrow Transplantation Group and the Italian Pediatric Hematology Oncology Assocation. J Clin Oncol 13:352, 1995
17. Barrett AJ, Horowitz MM, Pollock BH, Zhang MJ, Bortin MM, Buchanan GR, Camitta BM, Ochs J, Graham-Pole J, Rowlings PA, Rim AA, Klein JP, Shuster JJ, Sobocinski KA, Gale RP: HLA-identical sibling bone marrow transplants versus chemotherapy for children with acute lymphoblastic leukemia in second remission. N Engl J Med 331:1253, 1994
18. Dopfer R, Henze G, Bender-Gotze C, Ebell W, Ehninger G, Friedrich W, Gadner H, Klingebiel T, Peters C, Riehm H, Suttorp M, Schmit H, Schmitz N, Siegert W, Stollmann-Gibbels B, Hartmann R, Niethammer D: Allogeneic bone marrow transplantation for childhood acute lymphoblastic leukemia in second remission after intensive primary and relapse therapy according to the BFM- and CoALL-protocols: Results of the German Cooperative Study. Blood 78:2780, 1991
19. Billett AL, Kornmehl E, Tarbell NJ, Weinstein HJ, Gelber RD, Ritz J, Sallan SE: Autologous bone marrow transplantation after a long first remission for children with recurrent acute lymphoblastic leukemia. Blood 81:1651, 1993
20. Chessells J, Leiper AD, Richards SM: A second course of treatment for childhood acute lymphoblastic leukaemia: Long-term follow-up is needed to assess results. Br J Haematol 86:48, 1994
21. Buhrer C, Hartmann R, Fengler R, Schober S, Arlt I, Loewke M, Henze G: Importance of effective central nervous system therapy in isolated bone marrow relapse of childhood acute lymphoblastic leukemia. Blood 83:3468, 1994
22. Relling MV, Mahmoud HH, Pui C-H, Sandlund JT, Rivera GK, Ribeiro RC, Crist WM, Evans WE: Etoposide achieves potentially cytotoxic concentrations in CSF of children with acute lymphoblastic leukemia. J Clin Oncol 14:399, 1996
23. Lipshullz SE, Colan SD, Gelber RD, Perez-Atayade AR, Sallan SE, Sanders SP: Late cardiac effects of doxorubicin therapy for acute lymphoblastic leukemia in childhood. N Engl J Med 324:808, 1991
24. Pratt CB, Pui C-H: Second tumors after treatment with anticancer drugs, in Powis G. Hacker MP (eds): The Toxicity of Anticancer Drugs. New York, NY, Pergamon, 1991, p 28
25. Pommier Y, Orr A, Kohn KW, Riou JF: Differential effects of amsacrine and epipodophyllotoxins on topoisomerase II cleavage in the human c-myc protooncogene. Cancer Res 52:3125, 1992
26. Pui C-H, Ribeiro RC, Hancock ML, Rivera GK, Evans WE, Raimondi SC, Head DR, Behm FG, Mahmoud MH, Sandlund JT, Crist WM: Acute myeloid leukemia in children treated with epipodophyllotoxins for acute lymphoblastic leukemia. N Engl J Med 325:1682, 1991
27. Rivera GK, Raimondi SC, Hancock ML, Behm FG, Pui CH, Abromowitch M, Mirro J Jr, Ochs JS, Look AT, Williams DL, Murphy SB, Dahl GV, Kalwinsky DK, Evans WE, Kun LE, Simone JV, Crist WM: Improved outcome in childhood acute lymphoblastic leukemia with reinforced early treatment and rotational combination chemotherapy. Lancet 337:61, 1991
28. Balis FM, Lester CM, Chrousos GP, Heideman RL, Poplack DG: Differences in cerebrospinal fluid penetration of corticosteroids: Possible relationship to the prevention of meningeal leukemia. J Clin Oncol 5:202, 1987
29. Clavell LA, Gelber RD, Cohen HJ, Hitchcock-Bryan S, Cassady JR, Tarbell NJ, Blattner SR, Tantravahi R, Leavitt P, Sallan SE: Four-agent induction and intensive asparaginase therapy for treatment of childhood acute lymphoblastic leukemia. N Engl J Med 315:657, 1986
30. Reiter A, Schrappe M, Ludwig WD, Hiddemann W, Sauter S, Henze G, Zimmermann M, Lampert F, Havers W, Niethammer D, Odenwald E, Ritter J, Mann G, Welte K, Gadner H, Riehm H: Chemotherapy in 998 unselected childhood acute lymphoblastic leukemia patients. Results and conclusions of the Multicenter Trial ALL-BFM 86. Blood 84:3122, 1994